Posts Tagged ‘Market Share’
Could drinking help thwart rheumatoid arthritis?
July 28th, 2010 | 
Author: 
Could drinking help thwart rheumatoid arthritis?
Drinking alcohol may help keep rheumatoid arthritis at bay, possibly because it dampens the body’s immune response, new research suggests.
Read more on KIVI Boise
In the Rheumatoid Arthritis Drug Market, the Uptake of Alternative Biologics Such as Roche/Chugai’s Actemra/RoActemra …
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the rheumatoid arthritis drug market, the uptake of alternative biologics such as Roche/Chugai’s Actemra/RoActemra will erode the market share of TNF-alpha inhibitors over the next decade.
Read more on PR Newswire via Yahoo! Finance
Alcohol consumption reduces risk of rheumatoid arthritis: Study
Drinking alcohol may reduce the severity of rheumatoid arthritis according to new research published today. It is the first time that this effect has been shown in humans. The study also finds that alcohol consumption reduces the risk of developing the disease, confirming the results of previous studies.
Read more on News-Medical-Net
Posted in Rheumatoid Arthritis | 
Tags: Actemra, Advisory Firms, Alcohol Consumption, Arthritis, Arthritis Rheumatoid, biologics, Chugai, could, Decision Resources, Drinking, Drinking Alcohol, Healthcare Issues, Help, Immune Response, Kivi Boise, Leading Research, Market Share, Pr Newswire, Rheumatoid, Rheumatoid Arthritis, Rheumatoid Arthritis Drug, Roche, Severity, thwart, Tnf Alpha | 
No Comments »
